
News from Banning Record Gazette
Top Banning Record Gazette News

Breast Cancer · GilbertThe VENTANA HER2 (4B5) test is now CE-IVDR approved to aid in the assessment of HER2-ultralow status to identify metastatic breast cancer patients who may be eligible for treatment with ENHERTU.The VENTANA HER2 (4B5) test is also now approved to…See the Story
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
90% Center coverage: 10 sources